Your browser doesn't support javascript.
loading
Fragment-based discovery of DNA gyrase inhibitors targeting the ATPase subunit of GyrB.
Mesleh, Michael F; Cross, Jason B; Zhang, Jing; Kahmann, Jan; Andersen, Ole A; Barker, John; Cheng, Robert K; Felicetti, Brunella; Wood, Michael; Hadfield, Andrea T; Scheich, Christoph; Moy, Terence I; Yang, Qingyi; Shotwell, Joseph; Nguyen, Kien; Lippa, Blaise; Dolle, Roland; Ryan, M Dominic.
Afiliación
  • Mesleh MF; Cubist Pharmaceuticals, 65 Hayden Ave., Lexington, MA 02421, United States.
  • Cross JB; Cubist Pharmaceuticals, 65 Hayden Ave., Lexington, MA 02421, United States.
  • Zhang J; Cubist Pharmaceuticals, 65 Hayden Ave., Lexington, MA 02421, United States.
  • Kahmann J; Evotec AG, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany.
  • Andersen OA; Evotec (UK) Ltd., 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, UK.
  • Barker J; Evotec (UK) Ltd., 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, UK.
  • Cheng RK; Evotec (UK) Ltd., 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, UK.
  • Felicetti B; Evotec (UK) Ltd., 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, UK.
  • Wood M; Evotec (UK) Ltd., 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, UK.
  • Hadfield AT; Evotec (UK) Ltd., 114 Innovation Drive, Milton Park, Abingdon OX14 4RZ, UK.
  • Scheich C; Evotec AG, Manfred Eigen Campus, Essener Bogen 7, 22419 Hamburg, Germany.
  • Moy TI; Cubist Pharmaceuticals, 65 Hayden Ave., Lexington, MA 02421, United States.
  • Yang Q; Cubist Pharmaceuticals, 65 Hayden Ave., Lexington, MA 02421, United States.
  • Shotwell J; Cubist Pharmaceuticals, 65 Hayden Ave., Lexington, MA 02421, United States.
  • Nguyen K; Cubist Pharmaceuticals, 65 Hayden Ave., Lexington, MA 02421, United States.
  • Lippa B; Cubist Pharmaceuticals, 65 Hayden Ave., Lexington, MA 02421, United States.
  • Dolle R; Cubist Pharmaceuticals, 65 Hayden Ave., Lexington, MA 02421, United States.
  • Ryan MD; Cubist Pharmaceuticals, 65 Hayden Ave., Lexington, MA 02421, United States.
Bioorg Med Chem Lett ; 26(4): 1314-8, 2016 Feb 15.
Article en En | MEDLINE | ID: mdl-26786695
Inhibitors of the ATPase function of bacterial DNA gyrase, located in the GyrB subunit and its related ParE subunit in topoisomerase IV, have demonstrated antibacterial activity. In this study we describe an NMR fragment-based screening effort targeting Staphylococcus aureus GyrB that identified several attractive and novel starting points with good ligand efficiency. Fragment hits were further characterized using NMR binding studies against full-length S. aureus GyrB and Escherichia coli ParE. X-ray co-crystal structures of select fragment hits confirmed binding and suggested a path for medicinal chemistry optimization. The identification, characterization, and elaboration of one of these fragment series to a 0.265 µM inhibitor is described herein.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Bacterianas / Girasa de ADN / Inhibidores de Topoisomerasa II / Antibacterianos Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Bacterianas / Girasa de ADN / Inhibidores de Topoisomerasa II / Antibacterianos Idioma: En Revista: Bioorg Med Chem Lett Asunto de la revista: BIOQUIMICA / QUIMICA Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido